- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 6, 2026 | 1.55M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.55M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 1.58M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $201K |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $206K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $704K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $568K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $22.13M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $15.49M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $18.8M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $16.26M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $38.97M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $39.05M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $37.41M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $36.68M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $171.73M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $167.86M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $210.71M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $206.91M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.21 |
| Eps Diluted | Q1 2026 · Sep 30, 2025 | $0.21 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.18 |
| Eps Diluted | Q1 2026 · Sep 30, 2024 | $0.18 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.21 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.18 |
| Net Income | Q1 2026 · Mar 31, 2026 | $318K |
| Net Income | Q1 2026 · Mar 31, 2025 | $285K |
| Capex restated | Q1 2026 · Mar 31, 2025 | $3.35M |